108 related articles for article (PubMed ID: 3681426)
1. Drug cytotoxicity at elevated temperature. In vitro study on the U-87MG glioma cell line.
Da Silva VF; Raaphorst GP; Goyal R; Feeley M
J Neurosurg; 1987 Dec; 67(6):885-8. PubMed ID: 3681426
[TBL] [Abstract][Full Text] [Related]
2. Intracerebral growth of a human glioma tumor line in athymic mice and treatment with procarbazine, 1,3-bis(2-chloroethyl)-1-nitrosourea, aziridinylbenzoquinone, and cis-platinum.
Schold SC; Rawlings CE; Bigner SH; Bigner DD
Neurosurgery; 1983 Jun; 12(6):672-7. PubMed ID: 6683794
[TBL] [Abstract][Full Text] [Related]
3. Experimental combination chemotherapy: intracarotid versus intravenous administration of aziridinylbenzoquinone, BCNU, and cisplatin in dogs.
Wright KC; Stephens LC; Wallace S; Savaraj N; Feun LG
Chemotherapy; 1987; 33(6):437-44. PubMed ID: 3428010
[TBL] [Abstract][Full Text] [Related]
4. Intra-arterial and intravenous chemotherapy for the treatment of malignant glioma. Preliminary results.
Calvo FA; Pastor MA; Dy C; Alegría E; Antón Aparicio LM; Gil A; Harguindey S; Zubieta JL; Martinez Lage M
Am J Clin Oncol; 1985 Jun; 8(3):200-9. PubMed ID: 4050738
[TBL] [Abstract][Full Text] [Related]
5. Comparison of in vitro cloning assays for drug sensitivity testing of human brain tumours.
Berens ME; Giblin JR; Dougherty DV; Hoifodt HK; Tveit K; Rosenblum ML
Br J Neurosurg; 1988; 2(2):227-34. PubMed ID: 3267306
[TBL] [Abstract][Full Text] [Related]
6. Intracerebral chemotherapy in the 9L rat brain tumor model.
Kimler BF; Liu C; Evans RG; Morantz RA
J Neurooncol; 1992 Nov; 14(3):191-200. PubMed ID: 1281224
[TBL] [Abstract][Full Text] [Related]
7. Hyperthermic potentiation of BCNU toxicity in BCNU-resistant human glioma cells.
Da Silva VF; Feeley M; Raaphorst GP
J Neurooncol; 1991 Aug; 11(1):37-41. PubMed ID: 1919644
[TBL] [Abstract][Full Text] [Related]
8. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard.
Evans CG; Bodell WJ; Tokuda K; Doane-Setzer P; Smith MT
Cancer Res; 1987 May; 47(10):2525-30. PubMed ID: 2882834
[TBL] [Abstract][Full Text] [Related]
9. Decreased cytotoxicity of aziridinylbenzoquinone caused by polyamine depletion in 9L rat brain tumor cells in vitro.
Alhonen-Hongisto L; Deen DF; Marton LJ
Cancer Res; 1984 Jan; 44(1):39-42. PubMed ID: 6418379
[TBL] [Abstract][Full Text] [Related]
10. Response variability of human brain tumors to AZQ in tissue culture.
Kornblith PL; Rosa L; Bona JD; Edwards JA; Matuzic N; Hirschfeld A; Hawkins C
J Neurooncol; 1986; 4(1):49-54. PubMed ID: 3746385
[TBL] [Abstract][Full Text] [Related]
11. Combined modality treatment using radiation and/or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model.
Slagel DE; Feola J; Houchens DP; Ovejera AA
Cancer Res; 1982 Mar; 42(3):812-6. PubMed ID: 7059979
[TBL] [Abstract][Full Text] [Related]
12. Intravenous BCNU and AZQ in patients with recurrent malignant gliomas.
Yung WK; Harris MI; Bruner JM; Feun LG
J Neurooncol; 1989 Sep; 7(3):237-40. PubMed ID: 2795118
[TBL] [Abstract][Full Text] [Related]
13. Formation and repair of 1,3-bis-(2-chloroethyl)-1-nitrosourea and cisplatin induced total genomic DNA interstrand crosslinks in human glioma cells.
Ali-Osman F; Rairkar A; Young P
Cancer Biochem Biophys; 1995 Jan; 14(4):231-41. PubMed ID: 7767897
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for malignant gliomas of the brain: a review of ten-years experience.
Paoletti P; Butti G; Knerich R; Gaetani P; Assietti R
Acta Neurochir (Wien); 1990; 103(1-2):35-46. PubMed ID: 2360465
[TBL] [Abstract][Full Text] [Related]
15. [Anticancer drug induced sister chromatid exchange and correlation to cell survival in human brain tumor cells].
Aida T; Bodell WJ
No To Shinkei; 1987 Mar; 39(3):235-41. PubMed ID: 3472531
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapeutic trials with hamster mesothelioma 10-24: responses to azacitidine, aziridinylbenzoquinone, cisplatin, and PCNU.
Holiat SM; Smith WE; Hubert DD; Davis S
Cancer Treat Rep; 1981; 65(11-12):1113-5. PubMed ID: 6170430
[TBL] [Abstract][Full Text] [Related]
17. Effect of AZQ (1,4-cyclohexadiene-1,4-diacarbamic acid-2,5-bis(1-aziridinyl)-3,6 -dioxodiethylester) in recurring supratentorial malignant brain gliomas--a Phase II study. EORTC Brain Tumour Cooperative Group.
Eur J Cancer Clin Oncol; 1985 Jan; 21(1):143-6. PubMed ID: 4038653
[No Abstract] [Full Text] [Related]
18. Combination of aziridinylbenzoquinone and cis-platinum with radiation therapy in the 9L rat brain tumor model.
Kimler BF; Liu C; Evans RG; Morantz RA
Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):445-50. PubMed ID: 8514542
[TBL] [Abstract][Full Text] [Related]
19. The role of BCNU polymer wafers (Gliadel) in the treatment of malignant glioma.
Nagpal S
Neurosurg Clin N Am; 2012 Apr; 23(2):289-95, ix. PubMed ID: 22440872
[TBL] [Abstract][Full Text] [Related]
20. Sister chromatid exchange induction in patients with anaplastic gliomas undergoing treatment with radiation plus diaziquone or 1,3-bis(2-chloroethyl)-1-nitrosourea.
Kligerman AD; Erexson GL; Wilmer JL; Schold SC
Cancer Res; 1987 Jan; 47(2):631-5. PubMed ID: 3791247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
